Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Extensive prediction of drug response in mutation-subtype-specific LUAD with machine learning approach.

Oncology research - 1 Jan 2023

Jia Kegang, Wang Yawei, Cao Q I, Wang Youyu

Abstract excerpt

Background: Lung cancer is the most prevalent cancer diagnosis and the leading cause of cancer death worldwide. Therapeutic failure in lung cancer (LUAD) is heavily influenced by drug resistance. This challenge stems from the diverse cell populations within the tumor, each having unique genetic, epigenetic, and phenotypic profiles. Such variations lead to varied therapeutic responses, thereby contributing to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Lung Neoplasms
Share to Machine Learning
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasm Recurrence, Local

Share to RNA, Messenger

Source

Open in PubMed Open full text

Identifiers

PMID: 38186568
DOI: 10.32604/or.2023.042863
PMCID: PMC10765129

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Extensive prediction of drug response in mutation-subtype-specific LUAD with machine learning approach.PMID 38186568Read ↗

Identification of a gefitinib resistance-associated signature for predicting prognosis and therapeutic response in lung adenocarcinoma via integrated multi-omics analysis and machine learningSemantic proximity Read ↗

Applications of Machine Learning to Predict Cisplatin Resistance in Lung CancerSemantic proximity Read ↗

Integrative Machine Learning Framework for Detecting Resistance-Associated Mutations in Cancer Cell LinesSemantic proximity Read ↗

Integrative Machine Learning Framework for Detecting Resistance-Associated Mutations in Cancer Cell LinesSemantic proximity Read ↗

Applications of Machine Learning to Predict Cisplatin Resistance in Lung CancerSemantic proximity Read ↗

An Ensemble Learning Approach for Cancer Drug PredictionSemantic proximity Read ↗

Bioinformatics and Experimental Validation for Identifying Biomarkers Associated with AMG510 (Sotorasib) Resistance in KRASG12C-Mutated Lung Adenocarcinoma.Semantic proximity Read ↗

Multi-omics identification of GPCR gene features in lung adenocarcinoma based on multiple machine learning combinationsSemantic proximity Read ↗

Identification and experimental verification of a novel cisplatin resistance-related lncRNA signature for predicting prognosis and immune response in lung adenocarcinoma.Semantic proximity Read ↗

Machine learning based personalized drug response prediction for lung cancer patients.Semantic proximity Read ↗

Computational Methods for the Analysis and Prediction of EGFR-Mutated Lung Cancer Drug Resistance: Recent Advances in Drug Design, Challenges and Future Prospects.Semantic proximity Read ↗

D3EGFR: a webserver for deep learning-guided drug sensitivity prediction and drug response information retrieval for EGFR mutation-driven lung cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.